Skip to content

    Alzheimer's Disease Health Center

    Font Size
    A
    A
    A

    Brain Stimulation Shows Promise Against Alzheimer's

    German pilot study found four of six patients kept, improved their memories one year later

    WebMD News from HealthDay

    By Randy Dotinga

    HealthDay Reporter

    TUESDAY, May 6, 2014 (HealthDay News) -- Four of six Alzheimer's patients responded to deep brain stimulation in a pilot study, German researchers report.

    Meanwhile, 42 Alzheimer's patients in the United States and Canada have been enrolled in the largest study to date to examine the use of deep brain stimulation to treat the disease.

    There are caveats about the research, even though deep brain stimulation is already used as a treatment for Parkinson's disease.

    "The research is very preliminary. We have good intentions, but there has to be rigorous testing with a 'control' group," said Dr. Stephen Salloway, director of neurology and the Memory and Aging Program at Brown University, in Rhode Island.

    Still, "we're opening a new era of exploration for Alzheimer's treatment," said Salloway, who studies brain stimulation. His hospital, Butler Hospital in Providence, R.I., is taking part in the new, larger study that's enrolled patients.

    There's no cure for Alzheimer's disease, and physicians have no way to stop it from getting worse and robbing patients of their memory and ability to function.

    "Medications may help patients have a better quality of life, but probably don't have any long-term effect in terms of slowing down the disease or improving their life expectancy," said Dr. Ricardo Osorio, a research assistant professor at the New York University School of Medicine.

    Enter deep brain stimulation. It's best known as a treatment that helps patients with advanced Parkinson's disease regain control of their movements. The treatment uses electrodes to continuously zap the brain with pulses of electricity.

    In the German study, researchers tested brain stimulation on six patients with mild to moderate Alzheimer's disease. They targeted a part of the brain known as the nucleus basalis of Meynert. This region has been linked to a neurotransmitter called acetylcholine, which helps the brain think properly.

    The brains of the patients were stimulated for 11 months after they went through a month of two weeks on and two weeks off treatment. Over the year, the memory skills of four patients stayed stable or improved while memory declined in two others.

    Today on WebMD

    Remember your finger
    When it’s more than just forgetfulness.
    man eating potato chips close up
    These may harm your cognition.
     
    senior man
    Common symptoms to look for.
    mri scan of human brain
    Can drinking red wine reverse the disease?
     
    Checklist
    ARTICLE
    eating blueberries
    ARTICLE
     
    clock
    Article
    Colored mri of brain
    ARTICLE
     
    Human brain graphic
    ARTICLE
    mature woman
    ARTICLE
     
    Woman comforting ailing mother
    ARTICLE
    Senior woman with serious expression
    ARTICLE